Suraksha Diagnostic Hosts Scientific Session on Advances in Genetics and Reproductive Health

Kolkata: Suraksha Diagnostic Limited (Suraksha Clinic and Diagnostics), one of Eastern India’s leading diagnostic chains, organized an insightful scientific session on “Advances in Genetics and Reproductive Health.”

The session featured internationally renowned experts who shared their perspectives on the evolving field of prenatal, postnatal, and preimplantation genetic testing.

The event was attended by Dr Michael Richardson, Senior Director, APAC, Yourgene Health, who discussed advancements in Non-Invasive Prenatal Testing (NIPT) and confirmatory testing; Dr Xin Yue Chan, Product Specialist (Reproductive Health), APJ, Thermo Fisher Scientific, who spoke about CytoMicroArray applications in prenatal and postnatal genetic analysis; and Mr. Alain Rico, Senior Product Manager, LSG, Thermo Fisher Scientific, who presented on Preimplantation Genetic Testing for Aneuploidy (PGT-A) and its future scope.

Experts highlighted how genomics has revolutionized the early detection of genetic disorders, enabling timely medical intervention and reducing treatment costs.

India reports nearly 70 million people affected by rare diseases, with up to 70% of these conditions occurring in children, underscoring the importance of early diagnosis.

With India’s Total Fertility Rate now at 1.9 below the replacement level of 2.1 families are opting for fewer pregnancies, increasing the demand for NIPT, Microarray, and PGT-A testing to ensure healthy pregnancies and safe childbirth.

According to IMARC Group, the Non-Invasive Prenatal Testing (NIPT) market in India, currently valued at $0.40 billion (2024), is expected to reach $1.20 billion by 2033, growing at a CAGR of 11.5%.

The rise is driven by increasing maternal age, better awareness, improved healthcare infrastructure, and advancements in screening technology.

Speaking on the occasion, Dr Somnath Chatterjee, Chairman and Joint Managing Director of Suraksha Clinic and Diagnostics, said, “Reproductive genomics has transformed maternal and fatal healthcare.

Suraksha Diagnostics serves as a one-stop centre that integrates advanced genomic tools with expert cytogenetic interpretation to ensure accurate diagnosis and improved reproductive health outcomes.”